{'fraction_non_alphanumeric': 0.017077798861480076, 'fraction_numerical': 0.0, 'mean_word_length': 5.36144578313253, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The patterns of outpatient off‐label carbamazepine use and the potential impact of regulatory labelling process in Taiwan

Background  Carbamazepine has been associated with severe cutaneous adverse drug reactions (ADR). It is important for patients with these ADRs under off‐label prescriptions are not eligible for drug injury relief in Taiwan. We conducted a study to depict the demography and possible factors related to the off‐label carbamazepine use in Taiwan. We also explored the policy influence of carbamazepine use.